NFKB1 and neoplasm: When M1-sEVs were used as the carrier of paclitaxel (PTX) to prepare nanomaterials (PTX-M1-sEVs), it could not only deliver a large amount of PTX to the tumor site safely and effectively but also activate the NF-κβ pathway and enhance the pro-inflammatory environment and anti-tumor activity.